| Keywords: |
immunohistochemistry; survival; cancer chemotherapy; cancer survival; treatment outcome; survival analysis; cancer surgery; surgical technique; histopathology; mortality; review; drug efficacy; drug safety; multimodality cancer therapy; adjuvant therapy; cancer adjuvant therapy; cancer radiotherapy; comparative study; chemotherapy, adjuvant; combined modality therapy; radiotherapy, adjuvant; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; follow up; methodology; antineoplastic agent; cancer diagnosis; neoplasm staging; laparotomy; metastasis; computer assisted tomography; differential diagnosis; tomography, x-ray computed; pathology; biopsy; risk assessment; sarcoma; algorithm; biopsy, needle; adjuvant chemotherapy; needle biopsy; fluorodeoxyglucose f 18; brachytherapy; thorax radiography; retroperitoneal tumor; retroperitoneal neoplasms; diagnostic test; retroperitoneal sarcoma; humans; prognosis; human; male; female
|
